132 related articles for article (PubMed ID: 1450060)
41. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
42. Outcome of patients with non-Hodgkin's lymphoma of the stomach after gastrectomy: clinicopathologic study and reclassification according to the revised European-American lymphoma classification.
Mafune KI; Tanaka Y; Suda Y; Izumo T
Gastric Cancer; 2001; 4(3):137-43. PubMed ID: 11760079
[TBL] [Abstract][Full Text] [Related]
43. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
[TBL] [Abstract][Full Text] [Related]
44. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
Patte C; Kalifa C; Flamant F; Hartmann O; Brugières L; Valteau-Couanet D; Bayle C; Caillaud JM; Lemerle J
Med Pediatr Oncol; 1992; 20(2):105-13. PubMed ID: 1734214
[TBL] [Abstract][Full Text] [Related]
45. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
46. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Swan F; Velasquez WS; Tucker S; Redman JR; Rodriguez MA; McLaughlin P; Hagemeister FB; Cabanillas F
J Clin Oncol; 1989 Oct; 7(10):1518-27. PubMed ID: 2674337
[TBL] [Abstract][Full Text] [Related]
47. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
48. A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma.
McMaster ML; Johnson DH; Greer JP; Wolff SN; Hildreth CR; Greco FA; Hainsworth JD
Cancer; 1991 Mar; 67(6):1487-92. PubMed ID: 1705861
[TBL] [Abstract][Full Text] [Related]
49. [Lymphatic neoplasias in young patients].
Borchmann P; Gökbuget N; Wulf G; Trümper L
Onkologie; 2011; 34 Suppl 5():6-11. PubMed ID: 21921661
[No Abstract] [Full Text] [Related]
50. [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
Kobayashi M; Sao H; Mizuta S; Kamiya O; Ohara K; Nagata K; Takeyama H; Watanabe E; Yamada H; Mizuno H
Rinsho Ketsueki; 1990 Oct; 31(10):1656-63. PubMed ID: 2255056
[TBL] [Abstract][Full Text] [Related]
51. Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
Johnson PW; Whelan J; Longhurst S; Stepniewska K; Matthews J; Amess J; Norton A; Rohatiner AZ; Lister TA
Br J Cancer; 1993 Apr; 67(4):792-7. PubMed ID: 8471438
[TBL] [Abstract][Full Text] [Related]
52. [Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].
Pisón Garcés J; Buñuel Alvarez JC; Domínguez Fenollé MP; Castillo Laita JA; Cenarro Guerrero T; Monreal Gálvez MJ; Arana Navarro T; Hernández Gayá A
An Esp Pediatr; 1991 Dec; 35(6):381-4. PubMed ID: 1793185
[TBL] [Abstract][Full Text] [Related]
53. Comparison of American Joint Committee on Cancer TNM-based staging system (7th edition) and Ann Arbor classification for predicting outcome in ocular adnexal lymphoma.
Rath S; Connors JM; Dolman PJ; Rootman J; Rootman DB; White VA
Orbit; 2014 Feb; 33(1):23-8. PubMed ID: 24180616
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Wilder DD; Ogden JL; Jain VK
Clin Lymphoma; 2002 Mar; 2(4):229-37. PubMed ID: 11970762
[TBL] [Abstract][Full Text] [Related]
55. Non-Hodgkin's lymphoma in Pakistan: a clinicopathological profile of 175 patients.
Aziz Z; Rehman A; Akram M; Saeed A
J Pak Med Assoc; 1999 Jan; 49(1):11-5. PubMed ID: 10463009
[TBL] [Abstract][Full Text] [Related]
56. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
57. Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group.
d'Amore F; Brincker H; Grønbaek K; Thorling K; Pedersen M; Jensen MK; Andersen E; Pedersen NT; Mortensen LS
J Clin Oncol; 1994 Aug; 12(8):1673-84. PubMed ID: 8040680
[TBL] [Abstract][Full Text] [Related]
58. Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Visco C; Medeiros LJ; Mesina OM; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera JE; Cabanillas F; Sarris AH
Clin Lymphoma; 2001 Jun; 2(1):40-6. PubMed ID: 11707869
[TBL] [Abstract][Full Text] [Related]
59. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
Esik O; Ikeda H; Mukai K; Kaneko A
Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
